Cargando…
Engineering a Novel Bivalent Oral Vaccine against Enteric Fever
Enteric fever is a major global healthcare issue caused largely by Salmonella enterica serovars Typhi and Paratyphi A. The objective of this study was to develop a novel, bivalent oral vaccine capable of protecting against both serovars. Our approach centred on genetically engineering the attenuated...
Autores principales: | Soulier, Annelise, Prevosto, Claudia, Chol, Mary, Deban, Livija, Cranenburgh, Rocky M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005139/ https://www.ncbi.nlm.nih.gov/pubmed/33807097 http://dx.doi.org/10.3390/ijms22063287 |
Ejemplares similares
-
Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever
por: Howlader, Debaki R., et al.
Publicado: (2018) -
A protective bivalent vaccine against Rift Valley fever and bluetongue
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020) -
Xer recombination for the automatic deletion of selectable marker genes from plasmids in enteric bacteria
por: Salerno, Paola, et al.
Publicado: (2022) -
A Genetically Engineered Bivalent Vaccine Coexpressing a Molecular Adjuvant against Classical Swine Fever and Porcine Epidemic Diarrhea
por: Wang, Hao, et al.
Publicado: (2023) -
Recombinant Duck Enteritis Virus-Vectored Bivalent Vaccine Effectively Protects Against Duck Hepatitis A Virus Infection in Ducks
por: Yang, Fuchun, et al.
Publicado: (2021)